Clinical Glomerulonephritis 4

8 Feb 2025 5:30 p.m. 6:30 p.m.

Umapati Hegde Moderator

Time	Session

12 a.m. 12 a.m.	LUPUS NEPHRITIS IN PEDIATRICS: A CASE SERIES WCN25-AB-2721, Poster Board= SAT-148	EVALUATION OF TUBULOGLOMERULAR OUTCOME BY MEASURING PROTEINURIA AND URINARY NGAL AFTER INDUCTION BY MMF IN CLASS III/IV LUPUS NEPHRITIS WCN25-AB-2084, Poster Board= SAT-149	WHEN THE ANSWER IS IN THE URINARY SEDIMENT WCN25-AB-1069, Poster Board= SAT-150	STUDY OF CLINICAL SIGNIFICANCE OF IGM AND C3 GLOMERULAR DEPOSITIS IN PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS WCN25-AB-1081, Poster Board= SAT-151	C3 GLOMERULONEPHRITIS – A RARE CAUSE OF ACUTE GLOMERULONEPHRITIS IN A YOUNG MALE WITH HBH DISEASE WCN25-AB-2572, Poster Board= SAT-152	C3 GLOMERULONEPHRITIS: UNIQUE PRESENTATION AND ROLE OF GENETIC TESTING - NEW WINE IN A NEW BOTTLE WCN25-AB-1237, Poster Board= SAT-153	A STUDY ON TREATMENT OUTCOME OF LUPUS NEPHRITIS PATIENTS IN SOUTH INDIAN POPULATION WCN25-AB-1838, Poster Board= SAT-154	MYCOPHENOLATE MOFETIL VS TACROLIMUS IN PURE CLASS V LUPUS NEPHRITIS – A RANDOMISED COMPARATIVE STUDY WCN25-AB-1843, Poster Board= SAT-155	SECONDARY MEMBRANOUS NEPHROPATHY : LUPUS NEPHRITIS OR HEPATITIS B? – A DIAGNOSTIC DILEMMA WCN25-AB-1398, Poster Board= SAT-156	EFFICACY AND SAFETY OF DAILY ORAL STEROID AND CYCLOPHOSPHAMIDE VERSUS CYCLICAL STEROID AND CYCLOPHOSPHAMIDE IN ADULT PATIENTS WITH MEMBRANOUS NEPHROPATHY :A RANDOMIZED CONTROLLED TRIAL WCN25-AB-1553, Poster Board= SAT-157	HISTOPATHOLOGICAL SPECTRUM OF GLOMERULAR DISEASES IN A NORTH INDIAN TERTIARY CARE CENTER: A RETROSPECTIVE ANALYSIS WCN25-AB-2550, Poster Board= SAT-158	DIAGNOSTIC IMPORTANCE OF ELECTRON MICROSCOPY IN KIDNEY DISEASES. WCN25-AB-2732, Poster Board= SAT-159	SHORT TERM OUTCOMES OF LUPUS NEPHRITIS WCN25-AB-1700, Poster Board= SAT-160	CLINICAL SPECTRUM OF LUPUS NEPHRITIS IN CHILDREN WCN25-AB-2829, Poster Board= SAT-161	CLINICO-PATHOLOGICAL PROFILE AND OUTCOMES OF LUPUS NEPHRITIS: A SINGLE- CENTER EXPERIENCE IN SOUTH INDIA WCN25-AB-1660, Poster Board= SAT-162	FULMINANT SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT HIGHLIGHTING MULTI-ORGAN INVOLVEMENT AND THERAPEUTIC CHALLENGES WCN25-AB-3170, Poster Board= SAT-163	OVERLAP SYNDROME: A RARE TRIPLE-POSITIVE SYSTEMIC VASCULITIS: ANCA (MPO, PR3) AND ANTI-MBG WCN25-AB-2856, Poster Board= SAT-164	A RARE CASE OF MGRS – PGNMID WITH LIGHT CHAIN RESTRICTION ONLY WCN25-AB-3575, Poster Board= SAT-165	ELECTROLYTE IMBALANCE AS A PRESENTING FEATURE IN IGA NEPHROPATHY: A CASE REPORT WCN25-AB-2980, Poster Board= SAT-166	CLINICAL PROFILE, TREATMENT MODALITIES AND OUTCOME IN ANCA (ANTINEUTOPHILIC CYTOPLASMIC ANTIBODY) ASSOCIATED) VASCULITIS WITH KIDNEY INVOLVEMENT- A SINGLE CENTRE EXPERIENCE FROM SOUTH INDIA WCN25-AB-3629, Poster Board= SAT-167	CHRONICITY SCORE AND NOT MEST C SCORE IS A BETTER PREDICTOR OF PROGNOSIS IN IGA NEPHROPATHY WCN25-AB-4235, Poster Board= SAT-168	THERAPEUTIC PLASMA EXCHANGE (TPE) IN THE TREATMENT OF RENAL DISEASES: A SINGLE CENTER EXPERIENCE WCN25-AB-2435, Poster Board= SAT-169